Immunogen count | Anti-HPS ELISA anti-body titer 20th days | Anti-HPS ELISA anti-body titer 40th days | Mean ± Standard deviation | |
Dose per gram of the HPS infected liver | 6 ml = 20 doses | 1087, 1154, 1143, 1144, 1144, 1298, 1494, 1286, 1043, 994 = 1178.7 ± 145.44 | 1016, 1087, 1046, 1048, 1087, 1076, 1012, 1096, 1078, 875 = 1042.1 ± 65.77 | 1110.4 ± 130.30 |
7.5 ml = 25 doses | 1032, 1054, 1103, 1071, 1065, 1098, 1286, 965, 895, 1022 = 1059.1 ± 101.66 | 1054, 1064, 1063, 1064, 897, 1087, 1098, 1122, 1286, 1112 = 1084.7 ± 94.48 | 1071.9 ± 96.42 | |
9 ml = 30 doses | 954, 1021, 1024, 1025, 924, 996, 1094, 993, 1048, 129 = 1037.3 ± 101.79 | 1054, 1043, 1048, 1048, 1054, 1065, 954, 889, 987, 1242 = 1038.4 ± 91.24 | 1037.8 ± 94.09 | |
HPS tissue culture | TCID50 1 × 105.6 | 1071, 1112, 1115, 1115, 1076, 1284, 1194, 1112, 1144, 1054 = 1127.7 ± 67.68 | 1052, 1047, 1041, 1041, 1044, 1076, 1034, 1089, 1049, 1104 = 1052.5 ± 18.04 | 1092.10 ± 62.61 |
TCID50 1 × 104.6 | 954, 876, 982, 982, 989, 998, 998, 969, 1034, 997 = 977.9 ± 41.51 | 754, 572, 763, 767, 767, 796, 1087, 834, 732, 654 = 772.6 ± 133.1 | 875.25 ± 142.50 | |
TCID50 1 × 103.6 | 785, 783, 912, 784, 785, 788, 823, 794, 998, 712 = 816.4 ± 80.62 | 543, 586, 553, 553, 553, 512, 597, 675, 712, 596 = 588.00 ± 61.97 | 702.2 ± 136.4 | |
Positive Control Group (PCG) | 1044, 1050, 1054, 1054, 1017, 1071, 893, 1243, 1015, 90 = 1022.2 ± 105.4 | 1285, 1184, 1184, 1187, 1085, 1118, 1285, 1043, 1198, 1215 = 1170.4 ± 85.86 | 1096.30 ± 120.57 | |
Negative Control Group (NCG) | 34, 24, 42, 34, 43, 12, 32, 2, 24, 75 = 32.2 ± 19.73 | 56, 43, 78, 98, 98, 34, 74, 24, 48, 105 = 65.80 ± 28.90 | 49.00 ± 29.61 |